Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity-Reference-Cited by-同舟云学术

Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity

Published:2020-10-30 Issue:1 Volume:27 Page:87-95
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Gandhi Shipra,Pandey Manu R.,Attwood Kristopher,Ji Wenyan,Witkiewicz Agnieszka K.,Knudsen Erik S.^ORCID,Allen Cheryl,Tario Joseph D.,Wallace Paul K.,Cedeno Carlos D.,Levis Maria,Stack Suzanne^ORCID,Funchain Pauline,Drabick Joseph J.,Bucsek Mark J.,Puzanov Igor,Mohammadpour Hemn,Repasky Elizabeth A.,Ernstoff Marc S.

Funder

NCI

NIH

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Baicalin reduces chronic stress-induced breast cancer metastasis via directly targeting β2-adrenergic receptor;Journal of Pharmaceutical Analysis;2024-07

2. Crosstalk between the nervous system and tumor microenvironment: Functional aspects and potential therapeutic strategies;Cancer Letters;2024-07

3. Effects of chronic stress on cancer development and the therapeutic prospects of adrenergic signaling regulation;Biomedicine & Pharmacotherapy;2024-06

4. Impact of environmental temperature on the survival outcomes of breast cancer: A SEER-based study;Breast Cancer Research and Treatment;2024-05-20

5. Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancer;Nature Medicine;2024-05-13